Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories has expanded its global footprint by establishing a new wholly-owned subsidiary, Dr. Reddy’s Denmark ApS, in Denmark. This strategic move, aligning with the company’s main pharmaceutical and biotechnological business, involves the subsidiary promoting production and related activities in Denmark. The cash-funded acquisition makes Dr. Reddy’s Denmark ApS a step-down subsidiary of the parent company.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
